4 Top COVID Stocks to Buy in February
In the early days of the COVID-19 pandemic, coronavirus-themed stock investing was best left to investors with an appetite for higher risk. Vaccines were early stage and not only represented opportunity for big stock market rewards, but also for big share declines. But the situation has evolved. Low-risk investors can opt for coronavirus companies with late-stage programs and newly marketed products. And there still are plenty of earlier-stage companies to suit the needs of high-risk and growth investors.
Here, I'll talk about two stocks cautious investors may consider buying this month -- and two stocks aggressive investors may consider. There's something for everyone. Let's start with our lower-risk options.
Source Fool.com